Global Biologics and Biosimilars Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028

Global Biologics and Biosimilars Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028

This report elaborates on the market size, market characteristics, and market growth of the Biologics and Biosimilars industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Biologics and Biosimilars. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.

Key Points this Global Biologics and Biosimilars Market Report Include:

Market Size Estimates: Biologics and Biosimilars market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Biologics and Biosimilars market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Biologics and Biosimilars market
Segment Market Analysis: Biologics and Biosimilars market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Biologics and Biosimilars market situations and prospects in major and top regions and countries
Biologics and Biosimilars Market Competitive Landscape and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.
Biologics and Biosimilars Industry Chain: Biologics and Biosimilars market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Biologics and Biosimilars Industry News, Policies by regions
Biologics and Biosimilars Industry Porters Five Forces Analysis

Key players in the global Biologics and Biosimilars market are covered in Chapter 2:

Amgen
3sbio
Innovent
Dong Bao
CP Guojian
Johnson & Johnson
Changchun High Tech
Novartis
Pfizer
Sanofi-Aventis
Ganlee
Gelgen
Merck
Novo Nordisk
United Laboratories
Eli Lilly
Roche
Biotech
AbbVie

In Chapter 6 and Chapter 9, on the basis of types, the Biologics and Biosimilars market from 2018 to 2028 is primarily split into:

Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others

In Chapter 7 and Chapter 10, on the basis of applications, the Biologics and Biosimilars market from 2018 to 2028 covers:

Tumor
Diabetes
Cardiovascular
Hemophilia
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:

United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others

In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.

Chapter Outline


This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:

Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Biologics and Biosimilars market size in terms of revenue, sales volume, and average price.

Chapter 2 analyzes the main companies in the Biologics and Biosimilars industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.

Chapter 3 is an analysis of the competitive environment of Biologics and Biosimilars market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.

Chapter 4 is an analysis of the Biologics and Biosimilars industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.

Chapter 5 focuses on Biologics and Biosimilars market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.

Chapters 6-8 have segmented the Biologics and Biosimilars market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.

Chapters 9-11 provide detailed Biologics and Biosimilars market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.

Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.

Years considered for this report:

Historical Years: 2018-2022
Base Year: 2022
Estimated Year: 2023
Forecast Period: 2023-2028